Global Digital Health for Obesity Market Size, Trend & Opportunity Analysis Report, By Component (Software, Hardware, Services), By End User (Patients, Providers, Payers, Others), and Forecast 2025-2035.
Global Digital Health For Obesity Market Size & Opportunity Analysis & Forecast, 2025-2035
Market Definition and Introduction
The Global Digital Health for Obesity Market was valued at USD 57.75 billion in 2024 and is projected to reach USD 626.45 billion by 2035, expanding at a CAGR of 24.20% from 2025 to 2035. This exponential growth reflects rising obesity prevalence, increasing awareness about personalised care, expanding use of digital tools, and the integration of AI-driven solutions to support weight management interventions. With over 1 billion people globally affected by overweight or obesity, the urgent demand for scalable, tech-enabled solutions is reshaping healthcare delivery models.
Digital health for obesity encompasses a broad ecosystem of technology-enabled solutions aimed at prevention, treatment, and management of obesity through platforms such as mobile apps, wearables, telemedicine, AI-powered analytics, and remote monitoring systems. These platforms support users in setting goals, tracking lifestyle metrics, adhering to dietary regimes, and receiving clinical support virtually. Mobile applications like MyFitnessPal and Noom, and wearables such as Fitbit and Apple Watch, have transformed individualised engagement in obesity care. Telehealth consultations, digital therapeutics, and integration with GLP-1 medication therapies further augment the ecosystem.
The convergence of smart technology, behavioural science, and clinical expertise enables personalised and accessible care. This shift is particularly relevant in the context of healthcare consumerism, where patients are increasingly proactive in seeking tools that enable autonomy, affordability, and sustainability. Healthcare providers, payers, and employers are leveraging digital obesity care platforms to support long-term outcomes and reduce chronic disease burden. As public health systems grapple with rising obesity-linked comorbidities, including cardiovascular disease, diabetes, and certain cancers, digital health represents a critical tool in enhancing outcomes, controlling costs, and expanding equitable access to care.
Recent Developments in Industry
- In December 2023, Hims & Hers introduced its digital weight loss program featuring tracking tools, educational content, and medication access, although it currently excludes GLP-1 prescriptions. These highlights growing demand for accessible virtual weight loss support and mark the company-s strategic push into obesity management.
- In December 2023, Knownwell launched "Knownwell Teens," a hybrid virtual-in-person programme targeting 14 million U.S. adolescents struggling with obesity. The initiative reflects a rising trend in early intervention and age-specific digital obesity solutions.
- In July 2023, Alfie Health launched its AI-powered ObesityRx platform. The system creates personalised metabolic profiles and behavioural treatment plans. Among 300 trial users, the solution delivered an average 10-15% weight reduction in nine months, demonstrating the effectiveness of AI-personalised obesity care.
Market Dynamics
Global obesity crisis drives demand for scalable and personalised digital health interventions worldwide.
The global obesity epidemic, affecting over one billion individuals, is fuelling unprecedented demand for scalable, affordable weight management solutions. Obesity-linked chronic conditions such as type 2 diabetes, cardiovascular diseases, and sleep apnea have placed a significant burden on healthcare systems worldwide. Traditional in-person treatment approaches remain expensive, resource-intensive, and difficult to scale, creating a clear gap that digital health platforms are increasingly addressing. Wearables, AI-enabled analytics, and mobile applications now empower individuals with real-time tracking, behavioural modification support, and hyper-personalised care plans, especially in high-burden regions like the U.S., UK, and China.
Supportive regulatory frameworks and GLP-1 integration accelerate hybrid digital obesity care models.
Government initiatives such as the UK’s NHS Digital Health Strategy and China’s Healthy China 2035 framework are driving institutional investment in digital health. In the U.S., expanded telehealth waivers and reimbursement models are creating favourable conditions for virtual weight management services. Concurrently, the integration of GLP-1 medications, including Wegovy and Ozempic, into digital coaching platforms by players like Teladoc and Form Health is reshaping obesity care delivery. These hybrid models combine pharmacotherapy with teleconsultation and app-based coaching, setting a new standard for comprehensive obesity management.
Data privacy challenges and unequal access hinder market growth across global regions.
Despite strong momentum, handling sensitive health data remains a major restraint. Compliance with GDPR, HIPAA, and ISO standards is essential to ensure user trust, particularly among adolescents and vulnerable groups. Furthermore, unequal access to technology in low-resource markets limits scalability, with digital literacy gaps and infrastructure deficits slowing widespread adoption of digital obesity care solutions.
AI-driven personalisation and EHR integration unlock promising opportunities in digital obesity management.
The convergence of AI, predictive analytics, and cloud computing is enabling hyper-personalised care models and value-based interventions. Partnerships between digital platforms, healthcare providers, and pharmaceutical companies are expanding commercial opportunities, while direct-to-consumer subscription models open new revenue streams for industry players.
Long-term adherence, equitable access, and clinical integration remain global market challenges.
Sustaining user engagement, addressing socioeconomic disparities, and integrating digital tools into existing clinical pathways remain pressing concerns. Continuous innovation in gamification, behavioural science, and outcomes driven care delivery will be critical to ensuring long-term adoption and measurable impact.
Attractive Opportunities in the Market
- Real-time metabolic analysis enables personalised obesity management and adaptive treatment pathways.
- Subscription-based digital coaching combined with GLP-1 therapy improves weight-loss outcomes.
- Targeted mobile apps and gamified tools address adolescent obesity with early prevention strategies.
- Wearable-driven feedback loops boost adherence and support long-term behavioural change goals.
- Providers entering Asia-Pacific and Latin America address rising obesity and healthcare access gaps.
- Corporate obesity care initiatives reduce absenteeism and employer healthcare expenditure significantly.
- Virtual platforms integrate dieticians, psychologists, and physicians for holistic obesity management.
Report Segmentation
By Component: Software, Hardware, Services
By End User: Patients, Providers, Payers, Others
By Region: North America (U.S., Canada, Mexico)Europe (UK, Germany, France, Spain, Italy, Rest of Europe)Asia-Pacific (China, India, Japan, Australia, South Korea, Rest of Asia-Pacific)LAMEA (Brazil, Argentina, UAE, Saudi Arabia, Africa, Rest of Latin America)
Key Market Players: (WW International, MyFitnessPal, Teladoc Health, Fitness Keeper Inc., Healthify, Fitbit, Noom, PlateJoy HEALTH, Tempus, WellDoc, Sidekick Health, BioAge Labs)
Report Aspects
Base Year: 2024
Historic Years: 2022, 2023, 2024
Forecast Period: 2025-2035
Report Pages: 293
Dominating Segments
Services Segment Leads Digital Health for Obesity Market with Highest Revenue Contribution in 2024.
The services segment emerged as the largest revenue contributor in the global digital health for obesity market, accounting for a 37.9% share. The dominance of services is driven by the rising demand for installation, maintenance, training, and ongoing support required to operate advanced digital health platforms. Healthcare organisations increasingly rely on comprehensive pre- and post-deployment services to ensure seamless implementation, integration, and optimisation of technologies like EMRs and EHRs. As digital solutions continue to advance, the growing need for continuous upgrades and specialised expertise will sustain the leadership of services in this market.
Patient Segment Dominates End-Use Category with Strong Adoption of Self-Managed Digital Health Solutions.
The patient segment captured the largest revenue share of 34.5% in 2024, making it the dominant end-user group in the digital health for obesity market. This growth is fuelled by the global shift toward patient-centred care and the rising preference for digital tools that empower individuals to monitor and manage their health independently. Patients are increasingly using mobile apps, wearables, and virtual consultations to track weight, monitor vital parameters, and receive personalised guidance. With growing awareness about lifestyle-related disorders and greater access to digital platforms, patients remain the primary drivers of adoption in obesity-focused digital health solutions.
Key Takeaways
- The global digital health for obesity market was valued at USD 57.75 billion in 2024.
- Market projected to reach USD 626.45 billion by 2035 at 24.20% CAGR.
- North America led with a 36% revenue share in 2024; the U.S. remains dominant.
- The Asia-Pacific region is forecasted to grow at the highest CAGR.
- Services segment dominated by component, driven by coaching and monitoring.
- Software segment expected to grow rapidly with app and AI integration.
- The Patients segment captured the largest share by end user.
Regional Insights
North America leads digital obesity adoption with strong healthcare IT, pharma innovation, and telehealth integration
North America accounted for over 36% of the digital obesity market in 2024, led by the U.S. The region’s dominance stems from advanced healthcare IT infrastructure, high adoption of wearables, and digital-first consumers. The launch of Lilly Direct in 2024 highlights pharmaceutical companies’ shift towards direct-to-patient digital care models. Supportive telehealth reimbursement policies and collaborations between insurers, health systems, and digital health providers are accelerating the integration of virtual obesity management solutions, reinforcing North America’s leadership in tech-enabled obesity care ecosystems.
Europe expands digital obesity care through public health initiatives and regulated adolescent weight management programmes
Europe is witnessing the rapid adoption of telehealth and mobile weight-management applications, driven by NHS-led digital initiatives and Germany’s DiGA app reimbursement model. Partnerships such as Novo Nordisk’s collaboration with telehealth provider Kry are improving public access to obesity management services. The growing emphasis on adolescent obesity prevention and the integration of GLP-1 therapies into digital health ecosystems reflect Europe’s maturing digital healthcare market, with a strong focus on regulated, prevention-oriented, and population-wide interventions supported by both governments and private healthcare stakeholders.
Asia-Pacific accelerates digital obesity growth with government healthcare digitisation and AI-driven personalised interventions
Asia-Pacific is emerging as the fastest-growing digital obesity market due to rising obesity rates, urbanisation, and government-backed healthcare digitisation initiatives. India’s Ayushman Bharat programme and China’s “Internet Plus Healthcare” strategy are revolutionising access to digital obesity care. China leads the region in AI-enabled health platforms, wearables, and digital twin technologies, while Australia and Japan integrate obesity-focused virtual care into mainstream health systems. This regional momentum, supported by private investment and rising consumer health awareness, positions Asia-Pacific as a hotspot for digital healthcare innovation.
LAMEA region strengthens digital obesity adoption with telehealth expansion and proactive government-led healthcare reforms
The LAMEA region is gaining momentum, driven by Brazil’s public health initiatives and Saudi Arabia’s Vision 2030 healthcare transformation agenda. With 92% smartphone penetration in Saudi Arabia, virtual obesity management solutions are rapidly expanding. Pharmaceutical investments in AI-powered teleconsultations, combined with rising lifestyle-related obesity cases, are strengthening digital health infrastructure. Strategic collaborations between governments, NGOs, and healthcare providers are enabling sustainable growth of technology-enabled obesity care solutions across Latin America, the Middle East, and African healthcare markets.
Key Benefits for Stakeholders
- The report offers a quantitative assessment of market segments, emerging trends, projections, and market dynamics for the period 2024 to 2035.
- The report presents comprehensive market research, including insights into key growth drivers, challenges, and potential opportunities.
- Porter's Five Forces analysis evaluates the influence of buyers and suppliers, helping stakeholders make strategic, profit-driven decisions and strengthen their supplier-buyer relationships.
- A detailed examination of market segmentation helps identify existing and emerging opportunities.
- Key countries within each region are analysed based on their revenue contributions to the overall market.
- The positioning of market players enables effective benchmarking and provides clarity on their current standing within the industry.
- The report covers regional and global market trends, major players, key segments, application areas, and strategies for market expansion.
Frequently Asked Question(FAQ) :
The services segment is the leading contributor, accounting for a 37.9% market share in 2024. This dominance is driven by the intensive demand for installation, maintenance, training, and the ongoing clinical support required to operate advanced digital health platforms and electronic health records (EHRs).
The patient segment captured the largest revenue share of 34.5% in 2024. This is attributed to the global shift toward patient-centered care and a growing preference for self-managed tools such as mobile apps and wearables that empower individuals to monitor their own health metrics.
The market is primarily driven by the global obesity epidemic affecting over one billion people, the rising demand for scalable and affordable weight management, the integration of AI-powered personalized care, and the increasing synergy between digital coaching platforms and GLP-1 medications like Wegovy and Ozempic.
North America led the market with a 36% revenue share in 2024. Its dominance is fueled by advanced healthcare IT infrastructure, high consumer adoption of wearables, supportive telehealth reimbursement policies, and pharmaceutical innovations such as direct-to-patient digital care models.
The Asia-Pacific region is forecasted to grow at the highest CAGR. This rapid growth is supported by government-backed healthcare digitization initiatives (like China’s “Healthy China 2035” and India’s Ayushman Bharat), rising urbanization, and increasing investment in AI-enabled health platforms.
AI is enabling hyper-personalized care through real-time metabolic analysis, predictive analytics, and the creation of tailored behavioral treatment plans. For example, platforms like Alfie Health’s ObesityRx use AI to deliver significant weight reduction by personalizing metabolic profiles for users.
Key obstacles include stringent data privacy regulations (such as GDPR and HIPAA), the difficulty of maintaining long-term user engagement (avoiding "drop-off"), unequal access to technology in low-resource regions, and digital literacy gaps.
Corporate obesity care is an emerging opportunity where employers leverage digital platforms to reduce absenteeism and healthcare expenditures. By providing employees with digital tools for weight management, companies aim to improve overall productivity and reduce the burden of chronic diseases.
Major industry participants include WW International (WeightWatchers), Noom, Teladoc Health, MyFitnessPal, Fitbit, Healthify, Sidekick Health, and BioAge Labs, among others. These players are increasingly focusing on hybrid models that combine technology with clinical expertise.
